​   Publication​

1.  Jin, Y.; Lee, Y. "Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy" ChemMedChem. 2024, In press

2. Tong, Y. †; Lee, Y. †; Liu X. †; Child-Disney, J. †; Suresh, B.M.; Benhanou, R. I.; Yang, C.; Li, W.; Costales, M. G.; Haniff, H. S.; Sievers, S.; Abegg, D.; Wegner, T.; Paulisch, T. O.; Lekah, E.; Grefe, M.; Crynen, G.; Meter, M. V.; Wang, T.; Gibaut, Q. M. R.; Cleveland, J. L.; Adibekian, A.; Glorius, F.; Waldmann, H.; Disney, M. D; “Programming inactive RNA-binding small molecules into bioactive degraders” Nature, 2023, 618, 169-179 †Contributed equally

3. Kim, H.-S.; Lee, Y.; Shin, M. H.; Lim, H. S. "Cell-Penetrating, Amphipathic Cyclic Peptoids as Molecular Transporters for Cargo Delivery" Chem. Commun. 2021, 57, 6800-6803.

4. Lee, Y.; Heo, J.; Jeong, H.; Hong, K. T.; Kwon, D. H.; Shin, M. H.; Oh, M.; Sable, G. A.; Ahn, G.; Lee, J. S.; Lim, H. S. "Targeted Degradation of Transcription Co-activator SRC-1 through the N-Degron Pathway." Angew. Chem. Int. Ed. 2020, 59, 17548-17555.

5. Lee, Y.; Im, H.; Das, S.; Oh, M.; Lee, J. H.; Ham, S.; Lim, H. S. "Bridged α-helix mimetic small molecules." Chem. Commun. 2019, 55, 13311-13314.

6. Lee, Y.; Chung, B.; Ko, D. S.; Lim, H. S. "A solid-phase method for synthesis of dimeric and trimeric ligands: Identification of potent bivalent ligands of 14-3-3σ." Bioorg. Chem. 2019, 103141.

7. Castaneda, M.; Chen, L.; Pradhan, L.; Li, S.; Zein, R.; Lee, Y.; Lim, H. S.; Nam, H. J.; Lee, J. "A Forkhead Box Protein C2 inhibitor: Targeting Epithelial-mesenchymal Transition and Cancer Metastasis." Chembiochem. 2018, 19, 1359-1364.

8. Lee, Y.; Yoon, H.; Hwang, S. M.; Shin, M. K.; Lee, J. H.; Oh, M.; Im, S. H.; Song, J.; Lim, H. S.; “Targeted Inhibition of the NCOA1/STAT6 Protein-Protein Interaction” J. Am. Chem. Soc. 2017, 139, 16056-16059.

9. Lee, Y.; Lim, H. S. “Skp2 inhibitors: Novel anticancer strategies” Curr. Med. Chem. 2016, 23, 2363-2379.